Table 1.
Demographic and Clinical Characteristics of Patients in the Intention to Treat Population
| Characteristics | High-dose EA (n = 19) | Low-dose EA (n = 20) | Control Group (n = 19) |
|---|---|---|---|
| Age (year), mean ± SD | 55.00±12.41 | 58.75±8.85 | 53.95±12.19 |
| Gender | |||
| Male | 15 (78.95%) | 11 (55.00%) | 10 (52.63%) |
| Female | 4 (21.05%) | 9 (45.00%) | 9 (47.37%) |
| ECOG physical status score | |||
| 0 | 2 (10.53%) | 2 (10.00%) | 3 (15.79%) |
| (1–2)* | 17 (89.47%) | 18 (90.00%) | 16 (84.21%) |
| Stage | |||
| II | 5 (26.32%) | 6 (30.00%) | 7 (36.84%) |
| III | 14 (73.68%) | 14 (70.00%) | 12 (63.16%) |
| Resection extent | |||
| Total/proximal gastrectomy | 9 (47.37%) | 9 (45.00%) | 8 (42.11%) |
| Distal gastrectomy | 10 (52.63%) | 11 (55.00%) | 11 (57.89%) |
| Surgical approach | |||
| Laparoscope | 9 (47.37%) | 10 (50.00%) | 9 (47.37%) |
| Open surgery | 10 (52.63%) | 10 (50.00%) | 10 (52.63%) |
| Neo-adjuvant chemotherapy | |||
| Yes | 4 (21.05%) | 2 (10.00%) | 2 (10.53%) |
| No | 15 (78.95%) | 18 (90.00%) | 17 (89.47) |
| Days from surgery to adjuvant | |||
| chemotherapy, median (range) | 29 (20–58) | 30 (22–65) | 34 (19–52) |
| Number of acupoints, median (range) | 12 (10–14) | 12 (10–13) | - |
Abbreviations: EA = electro-acupuncture; SD = standard deviation; ECOG = Eastern Cooperative Oncology Group.
*
Only 1 patient in low-dose group was with ECOG PS=2.